Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brugger

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 17, 1999
Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clustersG Stuhler, A Zobywalski, F Grünebach, et al.
Experimental Hematology|March 18, 2000
Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietinK Kratz-Albers, S Scheding, R Möhle, et al.
Blood|December 1, 1995
Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrowD von Laer, U Meyer-Koenig, A Serr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
Blood|June 11, 1999
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapiesP Brossart, K S Heinrich, G Stuhler, et al.
Blood|September 25, 1999
The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitorsH J Bühring, P J Simmons, M Pudney, et al.
Annals of Hematology|October 24, 2000
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study GroupM Feuring-Buske, M Kneba, M Unterhalt, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2018
[Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example]F Griesinger, S Radke, A Lüers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cellsW Brugger, H J Bühring, F Grünebach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Peripheral blood progenitor cell transplantation: where do we stand? Chairman's Summary of the European School of Oncology Task Force meeting Peripheral Blood progenitor cell's held September 29-30, 1995M A Boogaerts, W Brugger, A M Carella, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|February 17, 1999
Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clustersG Stuhler, A Zobywalski, F Grünebach, et al.
Experimental Hematology|March 18, 2000
Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietinK Kratz-Albers, S Scheding, R Möhle, et al.
Blood|December 1, 1995
Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrowD von Laer, U Meyer-Koenig, A Serr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2016
Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab)M Rummel, T M Kim, F Aversa, et al.
Blood|June 11, 1999
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapiesP Brossart, K S Heinrich, G Stuhler, et al.
Blood|September 25, 1999
The monoclonal antibody 97A6 defines a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitorsH J Bühring, P J Simmons, M Pudney, et al.
Annals of Hematology|October 24, 2000
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study GroupM Feuring-Buske, M Kneba, M Unterhalt, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2018
[Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example]F Griesinger, S Radke, A Lüers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cellsW Brugger, H J Bühring, F Grünebach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Peripheral blood progenitor cell transplantation: where do we stand? Chairman's Summary of the European School of Oncology Task Force meeting Peripheral Blood progenitor cell's held September 29-30, 1995M A Boogaerts, W Brugger, A M Carella, et al.
Pageof 12